Q2 2026 brought significant legal and regulatory developments in life sciences across Norway and the EU. This quarterly update examines recent case law from the CJEU affecting distributor obligations under the MDR, online sales of non-prescription medicines, and SPC protection for substances classified as excipients, alongside regulatory updates including the provisional agreement on the Critical Medicines Act and EUDAMED becoming mandatory as of 28 May 2026.

Regulation (EU) 1235/2010 and Directive 2010/84/EU amending the legal framework regarding pharmacovigilance for medicinal products will enter into force in the European Union in July 2012.

When the lover's ex-wife was admitted to the hospital where the employee worked as a health professional, the employee opened and read the journal of the lover's ex-wife.

The Ministry of Health and Care has recently issued a hearing letter proposing stringent restrictions on import of medicinal products for personal use.

Whilst on holiday in Norway in 2011, a German tourist was injured following a car accident with a Norwegian national.

Advertising of medicinal products is governed by the Act on Medicinal Products of 4th December 1992 and by the appurtenant Regulation on medicinal products of 18th December 2009. In addition to these rules, the Association of the Pharmaceutical Industry (LMI) has provided several codes of practice for its members.